Clinical Trial Update: Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness [Phase 3]

View source ↗

Summary

Phase 3 trial update of brimonidine tartrate ophthalmic solution assessing efficacy and safety for ocular redness in adults and elderly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperemia

Drugs mentioned

• brimonidine tartrate ophthalmic solution (brimonidine tartrate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Hyperemia | Phase 3 | Status: COMPLETED | Results posted: 2019-10-23